Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuroInterventional Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
NeuroInterventional Therapeutics

NeuroInterventional Therapeutics

Acquired

NeuroInterventional Therapeutics, Inc.: Designing and manufacturing advanced catheter systems for cerebral care.

HQ
Pittsburgh, PA, US
Founded
2007
Overview
Compare
Fundraising
Employees

NeuroInterventional Therapeutics, Inc. designs and manufactures advanced catheter systems aimed at improving cerebral care. Their products focus on finding, trapping, and extracting thrombus in various cerebral vessels, addressing critical needs in neurointerventional procedures. The company is dedicated to enhancing patient outcomes through innovative medical technologies.

NeuroInterventional Therapeutics has made significant strides in the medical device industry, contributing to advancements in neurointerventional treatments. Their cutting-edge catheter systems have been recognized for their effectiveness in cerebral care, positioning the company as a key player in the field.

NeuroInterventional Therapeutics - Similar Companies

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

Thrombolex logo

Thrombolex

thrombolex.com

Galaxy Therapeutics logo

Galaxy Therapeutics

Cognition Medical logo

Cognition Medical

NeuroVasc Technologies logo

NeuroVasc Technologies

Advanced Catheter Therapies logo

Advanced Catheter Therapies

acatheter.com

Q'Apel Medical logo

Q'Apel Medical

qapelmedical.com

Scientia Vascular logo

Scientia Vascular

Nectero Medical logo

Nectero Medical

necteromed.com

NeuroVasx logo

NeuroVasx

Neurvana Medical logo

Neurvana Medical

Neuro42 logo

Neuro42

CereVasc logo

CereVasc

cerevasc.com

ClearPoint Neuro logo

ClearPoint Neuro

NeuroInterventional Therapeutics - Quick Facts

Who are NeuroInterventional Therapeutics' competitors?

Companies similar to NeuroInterventional Therapeutics include NeuRx Medical, Rist Neurovascular, Thrombolex and Galaxy Therapeutics.

When was NeuroInterventional Therapeutics founded?

NeuroInterventional Therapeutics was founded in 2007.

Where is NeuroInterventional Therapeutics' headquarters located?

NeuroInterventional Therapeutics' headquarters is located in Pittsburgh, PA, US.

How much has NeuroInterventional Therapeutics raised to-date?

As of Jun 10, 2010, NeuroInterventional Therapeutics has raised a total of $85k (USD).

NeuroInterventional Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
  • Medical
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research